The organization’s projected number of new diagnoses tops 2 million for the first time, with an increase in six of 10 most common cancers, according to a Jan. 17 news release from the American Cancer Society. Notably, colorectal cancer new cases have shifted mortality patterns in adults younger than 50 and have moved up from being the fourth leading cause of cancer death to the first in men and second in women.
Here are the most common new cancer types anticipated for men and women in 2024 by percentage of estimated growth in cases:
Men
Prostate: 29%
Lung and bronchus: 11%
Colon and rectum: 8%
Urinary bladder: 6%
Melanoma: 6%
Kidney and renal pelvis: 5%
Non-Hodgkin lymphoma: 4%
Oral cavity and pharynx: 4%
Leukemia: 4%
Pancreas: 3%
Women
Breast: 32%
Lung and bronchus: 12%
Colon and rectum: 7%
Uterine corpus: 7%
Melanoma: 4%
Non-Hodgkin lymphoma: 4%
Pancreas: 3%
Thyroid: 3%
Kidney and renal pelvis: 3%
Leukemia: 3%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
